Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4979152

O=C(O)C(F)(F)F.O=S(=O)(NCc1nonc1C(=NO)Nc1ccc(F)c(Cl)c1)C1CCNCC1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
ABL1 P00519 1/20 0.35
RECQL P46063 1/20 0.35
RIN1 Q13671 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
IDO1 P14902 3/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
IDH2 P48735 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NR1I2 O75469 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4979130 1.00 RORC (0.35) RORCKMT2AMEN1ALDH1A1ABL1
SCHEMBL14964250 0.95 IDO1 (0.37) RORCKMT2AMEN1ALDH1A1ABL1
SCHEMBL14442653 0.95 IDO1 (0.37) RORCKMT2AMEN1ALDH1A1ABL1
SCHEMBL5632116 0.89 IDO1 (0.39) RORCKMT2AMEN1ALDH1A1IDO1
SCHEMBL5632119 0.89 IDO1 (0.39) RORCKMT2AMEN1ALDH1A1IDO1
Trifluoroacetic Acid SCHEMBL5631788 0.89 IDO1 (0.38) RORCKMT2AMEN1IDO1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL5631796 0.89 IDO1 (0.38) RORCKMT2AMEN1IDO1SMN1; SMN2
SCHEMBL4979135 0.88 RORC (0.36) RORCKMT2AMEN1ALDH1A1ABL1
Trifluoroacetic Acid SCHEMBL5633955 0.88 IDO1 (0.38) RORCKMT2AMEN1ALDH1A1IDO1
SCHEMBL14461951 0.85 KMT2A (0.37) RORCKMT2AMEN1ALDH1A1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951536-B2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION (US) 2015-02-10 US claimed
US-20130177590-A1 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE CORPORATION (US) 2013-07-11 US claimed
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION 2007-08-09 US claimed
EP-1971583-B1 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE CORP (US) 2015-03-25 EP disclosed
US-8951536-B2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION (US) 2015-02-10 US disclosed
US-20130177590-A1 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE CORPORATION (US) 2013-07-11 US disclosed
EP-1971583-A2 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE Incyte Corporation (US) 2008-09-24 EP disclosed
WO-2007075598-A2 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE CORPORATION (US) 2007-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130177590-A1 N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE IDO1, IDO2, HNMT RORC 1427/4885KMT2A 545/4885MEN1 1163/4885
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase IDO1, IDO2, HNMT RORC 1427/4885KMT2A 545/4885MEN1 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.